rabbit polyclonal anti ezh2 antibody (Cell Signaling Technology Inc)
Structured Review

Rabbit Polyclonal Anti Ezh2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1099 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti ezh2 antibody/product/Cell Signaling Technology Inc
Average 96 stars, based on 1099 article reviews
Images
1) Product Images from "Gestational diabetes mellitus causes genome hyper-methylation of oocyte via increased EZH2"
Article Title: Gestational diabetes mellitus causes genome hyper-methylation of oocyte via increased EZH2
Journal: Nature Communications
doi: 10.1038/s41467-024-55499-x
Figure Legend Snippet: a differentially expressed genes (DEGs) analysis in F1 oocytes; b the association between DMRs located at promoter regions and DEGs; blue, downregulated DEGs; red, upregulated DEGs; c the mRNA expression of DNMT3a (p = 0.16794) and DNMT3l (p = 0.27292) in GDF1 oocytes; data presented as mean ± SD; d , e the mRNA expression of Ezh2 (p = 0.004) and Suz12 (p = 0.014) in GDF1 oocytes examined using qPCR; data presented as mean ± SD; f H3K27me3 modification in GV oocytes is examined using immunofluorescence and g the relative intensity of fluorescence is calculated using Image J; data presented as mean ± SD; NGDF1, n = 51; GDF1, n = 40; p = 0.01135; h the expression of EZH2 (n = 59) during folliculogenesis is examined using immunofluorescence histochemistry, and i the relative intensity fluorescence is calculated using Image J; data presented as mean ± SEM; n: primordial follicles = 28, primary follicles = 32, secondary follicles = 46, and antral follicles = 20 (p = 1.1527*10 −8 ); 8 ovaries from 8 mice were used; j the H3K27me3 (n = 36) modification in follicular development is examined, and k the relative intensity of fluorescence was calculated by Image J; data presented as mean ± SEM; n: primordial follicles=27, primary follicles = 38 (p = 1.0952*10 −12 ), secondary follicles = 33, and antral follicles = 19. *p < 0.05; **p < 0.01. Bar, 20 μm. FPKM, fragments Per Kilobase of exon model per Million mapped fragments. Source data are provided as a Source Data file. The statistical difference between groups was analyzed using two-tail t test.
Techniques Used: Expressing, Modification, Immunofluorescence, Fluorescence
Figure Legend Snippet: a , b inhibitors of EZH2 are used to inhibit the function of EZH2 in oocytes, and the H3K27me3 level is examined using immunofluorescence; control, n = 83; Dznep, n = 73 (p = 0.009185); Gsk343, n = 75 (p = 0.043357); c – e after inhibition of EZH2, the 5mC and 5hmC level in MII oocytes are examined using immunofluorescence; n: control=44, Dznep=56 (p = 0.007128), and Gsk343 = 36 (p = 0.021183) for 5mC, and control=42, Dznep=44 (p = 0.000235), and Gsk343 = 25 (p = 0.000834) for 5hmC; f , g Abca1 and Dact3 are target genes of EZH2, and the DNA methylation level of Abca1 (p = 0.000137 and 0.037005) and Dact3 (p = 0.017237 and 0.04808) is reduced by inhibiting the function of EZH2; data presented as percentage, and the statistical difference was examined using chi-square test; h – j when Ezh2 expression is knocked down in oocytes using siRNA, the genomic methylation level of 5mC and 5hmC is examined; n: control =27 and Ezh2 -siRNA = 58 (p = 0.010829) for 5mC, and control=13 and Ezh2 -siRNA =56 (p = 0.006307) for 5hmC; k – m with Ezh2 overexpression in oocytes, the 5mC and 5hmC level are examined using immunofluorescence; n: control =50 and Ezh2 -overexpressionn=63 for both of 5mC (p = 1.31743*10 −5 ) and 5hmC (p = 0.001759). *p < 0.05; **p < 0.01; ***p < 0.001; black circle, methylated CG; white circle, unmethylated CG. Bar, 20 μm. data presented as mean ± SEM. Source data are provided as a Source Data file.
Techniques Used: Immunofluorescence, Control, Inhibition, DNA Methylation Assay, Expressing, Methylation, Over Expression
Figure Legend Snippet: a , b EZH2 colocalizes with DNMT1 and DNMT3a in nucleus of GV oocytes; c – e Ezh2 expression knockdown reduces the level of EZH2 and DNMT1 at chromatin; n: control=48 and Ezh2 -siRNA=47 for EZH2 (p = 5.07772*10 −8 ), and control=19 and Ezh2 -siRNA=27 for DNMT1 (p = 2.62159 × 10 −5 ); and f – h Ezh2 overexpression increases the level of EZH2 and DNMT1 at chromatin, n: control=57 and Ezh2 -overexpression=45 for EZH2 (p = 4.54368 × 10 −7 ), and control=26 and Ezh2 -overexpression=22 for DNMT1 (p = 3.05373*10 −7 ); but i – l the level of DNMT3a at chromatin is not affected by Ezh2 knockdown (n: control=25 and Ezh2 -siRNA=20, p = 0.20404) and overexpression (n: control=31 and Ezh2 -overexpression=22, p = 0.227746). data presented as mean ± SEM. ****p < 0.00001; ns, no significant difference. Bar, 20 μm. Ezh2 -ov, Ezh2 overexpression; ns, no significant difference. Source data are provided as a Source Data file.
Techniques Used: Expressing, Knockdown, Control, Over Expression
Figure Legend Snippet: a , b the interaction of EZH2 with DNMT1 and DNMT3A and COCs (n = 2000) and oocytes (n = 5300) is examined using co-immunoprecipitation and Western-blotting; c the interaction between EZH2 and DNMT1 and DNMT3A in ovaries (n = 8) is examined using co-immunoprecipitation; d , e EZH2 is knockdown using siRNA in oocytes and the H3K27me3 level is examined using immunofluorescence (n: control=43 and Ezh2 -siRNA=46, p = 0.002896); f , g SUZ12 knockdown in oocytes is performed using siRNA, and the H3K27me3 level is examined (n: control=43 and Ezh2 -siRNA=48, p = 0.034347). *p < 0.05; **p < 0.01. Bar, 20 μm. H3K27me3, histone 3 lysine 27 trimethylation. data presented as mean ± SEM. Source data are provided as a Source Data file.
Techniques Used: Immunoprecipitation, Western Blot, Knockdown, Immunofluorescence, Control
Figure Legend Snippet: a the dynamics of EZH2 in follicular development of GDF1 are examined using immunofluorescence, and b the relative level of EZH2 in GDF1 is compared with NGDF1; n: NGDF1 = 23 and GDF1 = 20 for primordial follicles (p = 0.088426), NGDF1 = 25 and GDF1 = 22 for primary follicles (p = 0.896508), NGDF1 = 43 and GDF1 = 47 for secondary follicles (p = 0.942229), and NGDF1 = 16 and GDF1 = 15 for antral follicles (p = 0.67194); 8 ovaries from 8 mice were used; c H3K27me3 level in folliculogenesis of GDF1 is examined, and d the relative level of it is compared with NGDF1; n: NGDF1 = 23 and GDF1 = 22 for primordial follicles (p = 0.003264), NGDF1 = 34 and GDF1 = 30 for primary follicles (p = 1.65546*10 −5 ), NGDF1 = 30 and GDF1 = 25 for secondary follicles (p = 0.018598), and NGDF1 = 17 and GDF1 = 15 for antral follicles (p = 0.008278); 8 ovaries from 8 mice were used; e protein levels of DNMT3A and EZH2 in NGDF1 and GDF1 oocytes are examined using Western-blotting; f , g the level of DNMT3a in GDF1 oocytes is not affected by GDM compared with NGDF1 (n: NGDF1 = 19 and GDF1 = 18, p = 0.256458); h , i the mRNA expression of Dnmt1 (p = 0.655248), Uhrf1 (p = 0.898845) and Stella (p = 0.018583) in GDF1 oocytes (data presented as mean ± SD), but j , k the level of DNMT1 at chromatin is increased in GDF1 oocytes (n: NGDF1 = 14 and GDF1 = 15, p = 0.000605); l – n Ezh2 knockdown in GDF1 oocytes significantly decreased the level of 5mC and 5hmC (n: NGDF1 = 20, GDF1 = 30 (p = 0.041405), and Ezh2 -siRNA=16 (p = 0.005935) for 5mC,, and NGDF1 = 23, GDF1 = 30 (p = 0.017439), and Ezh2 -siRNA=16 (p = 0.034593) for 5hmC, p = ). *p < 0.05; **p < 0.01; ***p < 0.001; ns, no significant difference. Bar, 20 μm. data presented as mean ± SEM. Source data are provided as a Source Data file.
Techniques Used: Immunofluorescence, Western Blot, Expressing, Knockdown
